Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

NCT00842699 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT00842699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
March 31, 2011
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation